Bioimpedance measurements with the Body Composition Monitor (BCM) have been shown to improve fluid management in haemodialysis. However, there is a lack of a sufficiently robust evidence-base for use of the BCM outside of standard protocols. This study aims to define the error associated with BCM measurement using alternate paths and timings to allow the use of BCM with confidence in a range of clinical scenarios. BCM measurements were made in 48 healthy controls and in 48 stable haemodialysis patients before and immediately after dialysis. The effect of utilising alternative measurement paths was assessed using mixed effects models and the effect of measuring post-dialysis was assessed by comparing changes in BCM-measured overhydration (OH) with weight changes over dialysis. The data from healthy controls suggest that there is no difference in BCMmeasured OH between all the whole-body paths other than the ankle-to-ankle measurement. Dialysis patients showed similar results other than having higher BCMmeasured OH when measured across the site of a vascular access. There was good agreement between BCM-measured OH from the standard path and change in weight, suggesting post-dialysis measurements can be utilised. These results suggest BCM protocols can be flexible regarding measurement paths and timing of measurement to ensure as many patients as possible can benefit from the technology.
Introduction
Fluid management is an important part of care for haemodialysis patients (Wizemann et al., 2009) . There is growing evidence that the use of bioimpedance measurements with the body composition monitor (BCM; Fresenius Medical Care, Germany) can help guide fluid management and improve outcomes , Onofriescu et al., 2014 . However, there are few pragmatic studies that can help to inform the use of BCM outside of the strict protocol recommended for measurements and used in interventional studies, which can exclude a significant number of patients when BCM is used as part of routine care.
M
asurements should be made before dialysis with the patient in a supine position (Fresenius Medical Care, 2009 ). This is related to the effect that ultrafiltration (Abbas et al., 2014) and posture (Zhu et al., 1998) have on fluid distributions between body segments and that, due to the different shapes and sizes of the limbs, shifts in fluid between segments can have significant effects on the whole body impedance. Measurements should also be made from wrist-to-ankle as this is the only validated measurement path and should avoid peripheral access sites, due to the presence of anatomical changes. As such, the standard path that is supported by the BCM manufacturer is from wrist-to-ankle However, in practice these requirements would exclude a relatively large number of patients from having BCM measurements. The haemodialysis population is highly comorbid and is disproportionately prone to amputations and tissue viability problems. Heavily bandaged limbs, damaged skin and amputations can prevent the use of the standard measurement path, while some complications may not prevent a measurement but will significantly affect the quality of the measurement e.g. use of moisturisers, localised fluid accumulations or contact between body segments such as at the armpit or between the legs. Validated alternative paths would allow measurements to be made on patients who would have otherwise have been managed without BCM or managed based on poor quality data. There are also a number of situations where it would be helpful to make post-dialysis BCM measurements. Practicalities and staffing levels can sometimes make it difficult to carry out all necessary BCM measurements at the same time as putting patients on dialysis, while post-dialysis measurements also allow immediate action to be taken when intradialytic symptoms prompt a review of target weights.
The potential for the equivalence of impedance across different paths was demonstrated two decades ago using consecutive bioimpedance analysis (BIA) measurements on the right and left sides of the body (Lukaski et al., 1985) although the approach to analysis in BIA differs considerably to that of bioimpedance spectroscopy (BIS) (Kyle et al., 2004) , employed by the BCM. The only investigation to consider alternative paths with BIS measurements was in preliminary work for this study, where it was shown that BCM-measured overhydration (OH) from the wrist-to-wrist path is an acceptable alternative to the standard path . When considering post-dialysis measurements, it is accepted that haemodialysis induced changes in fluid distributions affect whole-body bioimpedance (Zhu et al., 1999) , but the clinical significance of this when using BCM needs clarification.
In order to allow greater understanding of the effect of making measurements outside the on body composition parameters, this study aimed to characterise the error associated with alternate measurements that could be clinical useful.
Methods

Subjects
Ethical approval was granted by a local ethics committee and all participants provided informed consent.
A cohort of healthy controls was recruited (n=48), stratified by age-decade and by sex, who had no history of kidney disease or heart failure, no visible fluid accumulations and no limb amputations. Additionally, a cohort of stable haemodialysis patients was recruited (n=48), being over 18 years old, having no visible localised fluid accumulations and achieving target weight. Haemodialysis prescriptions were for regimes of three sessions of four hours per week, dialysate temperature was 36 C and sodium was 137mmol/l as standard. Routine target weights were defined on the basis of clinical examination and BCM on indication.
Sample size
Pilot work comparing BCM measurements from wrist-to-wrist and from wrist-to-ankle showed standard deviations of the mean difference in OH of around 1.0 litres . Recruiting 48 subjects into each cohort would allow differences of 0.3 litres to be measured between the primary two paths at the level of 5% type I error with 80% power using a two sided t-test. This is deemed an acceptable sample size; differences below 0.3 litres will fall below the limits of reproducibility of the device (Wieskotten et al., 2013) .
Data collection
Healthy controls had height measured using a stadiometer and weight measured using calibrated scales. For haemodialysis patients, height was taken from their clinical notes and pre-and post-dialysis weights were obtained as part of normal care.
BCM measurements were made with the commercially available 4-electrode BCM on the standard path. For this, the impedance is measured between an electrode positioned on the wrist and an electrode on the ankle, while a small electric current is passed between two further electrodes positioned 10 cm distal to the measurement electrodes. Additionally, measurements were made with a modified BCM -the 8-electrode BCM -which had additional cables allowing leads to be connected to electrodes on both hands and both feet. This device automatically makes 17 consecutive BIS measurements, varying the electrodes used for the voltage and current paths as described in figure 1. This allows measurement of impedances of the six whole body paths ( figure 1, # 1-6 ), where the current and measurement electrodes define the same path through the body, as well as the impedances of individual segments (figure 1, # 11-16) (Gibson et al., 2008) , where the measurement electrodes define a region of the body that is different from the path of the current, thereby isolating particular regions for measurement of segmental impedances. 4-and 8-electrode BCM measurements were made on healthy subjects on one occasion while dialysis patients had measurements made pre-and post-dialysis. All 4-lead BCM measurements were checked visually for artefacts, and repeated until the difference in measured OH was no greater than 0.2 litres between readings (in almost all cases the discrepancy between the first and second readings was no more than 0.1 litre). The 8-electrode device does not display Cole-plots or body composition data to allow real-time assessment of artefacts or consistency, so repeat measurements were not made. Measurements of resistance, reactance and phase angle were made at the same 50 frequencies as in the standard BCM, for seventeen combinations of voltage and current (see fig. 1 ) and data was extracted for analysis. De Lorenzo et al. (De Lorenzo et al., 1997) giving the extracellular fluid (ECF) resistance (R E ) and intracellular fluid (ICF) resistance (R I ). The main objectives were focussed on body composition parameters which can only be found from the whole body measurements (measurements 1-6) using volume and body composition models (Moissl et al., 2006 for each individual path using optimised tissue hydration parameters (courtesy of Fresenius Medical Care R&D). This provided equivalent data to the standard 4-lead BCM device, which was validated by processing 4-lead BCM impedance data with the custom analysis programme and comparing the results with those calculated by the device (see appendix 1).
# Voltage Current Segments measured
Mixed-effects regression model
The use of mixed-effects regression allowed a model to be built that could account for the repeated measures on an individual from the 8-electrode BCM. This characterises the individual differences in fluid status and body composition and accounts for this when describing the differences between the paths at the cohort level.
A different mixed effects model was used to analyse each of the principal BCM parameters -OH, lean tissue mass (LTM) and adipose tissue mass (ATM) -and the models only included measurements of the 6 whole-body paths: right side; left side; right wrist-to-left ankle (cross 1); left wrist-to-right ankle (cross 2); wrist-to-wrist; and ankle-to-ankle. For healthy controls, subject was taken as the random effect and path, sex and age were taken as fixed effects. For haemodialysis patients, the same model set up was used, only with the addition of measurement time (pre-or post-dialysis), which was added as a simple predictor variable for the models of LTM and ATM and as an interaction term for the model of OH, to allow assessment of ultrafiltration associated changes in fluid distributions between the paths.
To present the data, results for a 60 year old female measured on the standard path acted as a reference (standard path was taken as wrist-to-ankle on the dominant side of the body for controls and on and the contralateral side of the body to the most recently used vascular access (VA) for dialysis patients). The mean value for the dependent variable measured on the standard path is presented separately for controls and pre-and post-dialysis for patients, with a 95% confidence interval and a p-value assessing against a null value of zero. For each of the other measurement paths, the difference compared to the reference path is detailed with 95% confidence interval and a p-value. Adjustments for age and sex in each model are given and also for measurement time in the models assessing LTM and ATM. Significance levels were set at 0.05. To examine each model, plots of standardised residuals against fitted values were used to check the assumption of homoscedasticity and a Q-Q plot of the residuals was used to assess normality.
Statistical analysis
To investigate the validity of post-dialysis measurements, the agreement between change in BCM-measured OH from the reference path and change in weight was assessed using BlandAltman analysis. Furthermore, the consistency of LTM and ATM from the start to end of dialysis was assessed based on the effect of measurement time in each of the mixed-effects models.
The estimate of R E from the curve-fitting routine was used as a marker of relative changes in fluid status during dialysis for comparisons between the five body segments (right arm, left arm, trunk, right leg and left leg), where the whole-body analysis models are not appropriate.
Bland Altman analysis was done using Analyse-it for Microsoft Excel (version 2.26). All other analy ' ' F Statistical Computing, Vienna, Austria).
Results
Healthy controls n=48
HD patients n=48 Age (years) 49 (17) The results from the mixed effects regression models for OH can be seen in tables 2 and 3 with the results for LTM and ATM in Appendix 3. For the models investigating OH and ATM, age and sex were not associated with OH, while both age and sex were associated with LTM in both healthy controls and haemodialysis patients. For the model of OH in dialysis patients, including measurement time as an interaction term made a significant difference compared to a model with measurement time as a simple predictor variable (p=0.02), indicating the effect of measurement time on OH is modulated by path. For the models of LTM and ATM, including measurement time as an interaction term did not make a difference to the model, suggesting that the effect of measurement time on LTM and ATM was not different between the paths. For these models, measurement time was included as a predictor variable to investigate the validity of post-dialysis measurements of LTM and ATM. 
Measurement
Use of alternate paths
The data from healthy controls show that there is no difference in BCM-measured OH between all the whole-body paths other than the ankle-to-ankle measurement, which had a difference of 0.8 litres (table 2) . Considering LTM and ATM, there was a significant difference between the reference path and most other paths, apart from the cross measurements, including higher LTM and lower ATM in the dominant arm and in the wristto-wrist path as compared to the reference path.
Haemodialysis patients showed different pre-dialysis patterns than subjects with normal renal function. In particular, there was a significant difference in pre-dialysis BCM-measured OH between the side of the body where vascular access was situated as compared to the contralateral side (0.4 litres; 95% CI: 0.08 to 0.76; table 3), although this effect was not present post-dialysis. Unlike controls, there was no difference in LTM or ATM between the sides (Appendix 3), despite the fact that vascular access is usually on the non-dominant side.
Using the 8-electrode BCM, the impedances of each limb individually can be isolated (figure 1), which can support the results of the regression models. The relative magnitudes of R E and R I in each limb expressed in relation to the corresponding value from the reference path (whole body measurement on dominant/non-VA side) can be seen in table 4. Estimation of R I has much greater uncertainty and for segmental measurements, especially, in the trunk, the data were largely uninformative. 
Segment
Use of post-dialysis measurements
There was good agreement between change in BCM-measured OH on the reference measurement path ([pre-dialysis OH] [post-dialysis OH]) with change in weight ( fig. 2 ; bias 0.3 kg, 95% CI -1.9 to 1.3 kg). In theory, LTM and ATM should not change over dialysis and although there was no significant change in LTM (-0.40 kg; p=0.1; 95% CI:-1.1 to 0.1; table A3) there was a difference observed for ATM (0.77 kg; p=0.01; 95% CI: 0.16 to 1.4; table A4).
Figure 2: Bland Altman analysis of the agreement of change in weight and change in OH
The use of measurement time as an interaction term in the models for dialysis patients showed that measured-OH changed by a different amount between the paths. The only statistically significant interaction was for the ankle-to-ankle path, which suggests that there is a greater change in BCM-measured OH across this path compared to the other paths. This is supported by looking at the segmental impedance data. If relative changes in R E over dialysis are used to indicate changes in fluid status, it can be seen that the greatest relative change is in the leg segments (table 5). 
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Discussion
Rationale for the need for flexible measurement protocols At a population level, it is becoming well accepted that using BCM as an aide in guiding fluid management in haemodialysis improves outcomes (Onofriescu et al., 2014 . In an uncomplicated individual with relatively common characteristics, standard measurement protocols -from wrist-to-ankle on one side of the body avoiding vascular access sites -and decision making algorithms are likely to be beneficial. Yet there is a lack of data to support use of BCM outside this standardised approach and there remains a great deal of uncertainty in utilisation of the technology in certain individuals. By making 8-electrode BCM measurements on healthy controls and dialysis patients, the effect of making a number of simple alterations to BCM measurements are characterised which will allow these measurements to be made with greater confidence.
Use of alternate paths
Measurements on healthy controls suggest there is no significant difference in OH from any whole-body path other than across the legs. In principle the models that were generated and validated for the standard path can be employed with alternate paths. Changing from a standard wrist-to-ankle measurement on one side of the body to a wrist-to-wrist or cross measurement will involve substitution of one limb for another and a change in the pathway through the trunk. Using the segmental resistances from dialysis patients in table 4, the different path resistances can be built from the segments and referenced to the standard path ( figure 3 ). For measurements of R E , substituting limbs and trunk paths does not significantly alter the overall path R E , for any of the whole body paths except the ankle-toankle path which is noticeably lower, consistent with results from the regression model. For the wrist-to-wrist path, the higher resistance of the arms seems to be compensated by a lower measured resistance for a current crossing the trunk from wrist-to-wrist than from wrist-to-ankle. For haemodialysis patients, it has been suggested that the presence of vascular access in a easurements of OH and so guidance suggests avoiding these paths. The evidence supporting this recommendation comes from studies using different bioimpedance with different analysis techniques to the BIS used in the BCM. Woodrow et al. used whole-body, single frequency BIA measurements to show decreased resistance in the fistula arm that was accompanied by increased arm circumference, suggesting increased excess fluid (Woodrow et al., 1997) , although this was not replicated in paediatrics (Avila et al., 2015) . More recently, two studies from a single centre using segmental BIA (SBIA) have reported that water and lean tissue content is different in the fistula and non-fistula arms (Panorchan et al., 2015 , Booth et al., 2011 . However, neither BIA or SBIA can adequately distinguish excess fluid from lean and adipose tissue, which left the possibility that the differences observed relate to differences in lean tissue alone rather than excess fluid, particularly given that fistulae tend to be placed in the non-dominant arm of patients. The results here confirm that the presence of a vascular access does tend to increase OH. However, the effect (mean: 0.4; 95% CI: 0.1 to 0.8 litres) is arguably negligible from a clinical perspective, when considering the overall uncertainty in target weight prescription.
Considering the model results for LTM and ATM in controls, it is important to note that the equivalence of OH across different paths does not translate to these compartments. Where accurate monitoring of body composition is important, the standard pathway is preferred and consistency is important. The dominant side has significantly increased LTM and reduced ATM as compared to the non-dominant side and the legs have increased LTM and reduced ATM compared to the arms (see Appendix 3). This is consistent with previous work using BIA on controls that demonstrated decreased resistance in the dominant arm compared to the non-dominant arm (Bedogni et al., 2002 ) and a decreased resistance of the legs compared to the arms (Lorenzo and Andreoli, 2003) as decreased resistance is linked with greater muscle mass through the higher proportion of water in muscle than fat.
Use of post-dialysis measurements
Considering the use of post-dialysis BCM measurements, change in body weight was compared to change in BCM-measured OH as there is no accepted gold standard measure of OH to validate post-dialysis measurements. In theory, the change in OH over dialysis should equal the change in body weight, while there should be no change in LTM or ATM. However, dialysis has been shown to perturb fluid distributions (Shulman et al., 2001 ) which can influence whole-body bioimpedance measurements (Zhu et al., 1999) . Fluid shifts from the limbs into the trunk manifest as an apparent decrease in ECF when measured by wholebody techniques and shifts from the trunk to the limbs as an increase in ECF (Lundvall et al., 1996) .
The results here suggest that post-dialysis BCM-measured OH has a small bias of around 0.3 litres, with limits of agreement of -1.9 to 1.3 litres. This supports the validation literature of the BCM which has shown that the change in BCM-measured OH over dialysis is comparable to the ultrafiltration volume . There are reasonably large limits of agreement which should be taken into account when making post-dialysis measurements, but these measurements were taken immediately after dialysis and it is reasonable to assume that they would be reduced if there was a time delay introduced between dialysis end and BCM measurement, as recommended by the manufacturer. El-Kateb et al. reported a similar dataset to that presented here with contrasting results, including a significant bias and limits of agreement three times larger than those observed in this study. This discrepancy seems likely to be due to artefactual BCM measurements and highlights the need for some expertise when making measurements . The BCM validation literature also suggests that a bias is introduced into measurements of LTM and ATM when measurements are made immediately after dialysis but within 30 minutes this becomes non-significant. Considering this, and the findings here, users should have a degree of caution using BCM-measured LTM and ATM from post-dialysis measurements.
Despite the good agreement between change in BCM-measured OH and change in weight, the model for OH did suggest there was a degree of ultrafiltration induced changes in fluid distribution, with a larger change in the lower limbs than the upper. This would suggest that relatively more fluid is recruited from the legs than the upper body which is largely in agreement with previous work. Measurements over the first 75 minutes of dialysis using BIS (Shulman et al., 2001 ) and over the whole haemodialysis session using SBIA (Zhu et al., 2008) and segmental BIS (Chanchairujira and Mehta, 2001 ) have demonstrated a greater fractional change in fluid in the legs as compared to arms and trunk. Abbas et al (Abbas et al., 2014) showed that there is a greater percentage removal of ECF from the legs than other 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 compartments but that as ultrafiltration rate is increased, there is a preferential recruitment of fluid from the trunk.
Study limitations
The study was not powered to address the multiple comparisons made by the models -the sample size was based on comparisons between the two primary whole-body paths only. A larger sample would allow better estimates of these different estimates. It would also have been interesting to extend the analysis to a group of haemodialysis patients who are defined as being prone to intradialytic hypotension (IDH), to investigate the relationship between fluid distributions, fluid dynamics and IDH.
Conclusions
In summary, these data helps BCM users make measurements and interpret results with greater confidence. Measurement protocols can be more flexible and individualised than , which will help as many patients as possible benefit from the technology. This is based on a number of key observations:
 Any of the whole body paths other than ankle-to-ankle can be used as an alternative to the standard path for measurement of OH by BCM, with an acknowledgement of the additional uncertainty when interpreting the results.  BCM-measured OH is greater when measuring across a site of vascular access, but the increase arguably is not clinically significant when the uncertainty in other methods of target weight assessment is considered.  Making BCM measurements post-dialysis introduces a negligible bias to OH measurements but does increase measurement uncertainty, which should be accounted for when interpreting such data. This uncertainty will be reduced with time after dialysis, such as asking patients to move off the dialysis station to be weighed, before a measurement is made.
with the programme and the agreement between the body composition parameters can be seen in figure A1 . For OH, the bias was 0.1 litres with 95% limits of agreement of around -0.1 to 0.3, showing very good agreement and verifying that the programmes are working similarly to commercial device analysis. For LTM and ATM, biases of -0.4 and 0.3 litres were observed with slightly larger confidence intervals. This is likely to be related to known issues in modelling R I which has a larger influence on LTM and ATM than OH. However, for the purposes of the study LTM and ATM are secondary outcome interests and the agreement was deemed sufficient. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 60
Appendix 2
The results from checks of each of the models can be seen in figures A2 -A4. Visual inspection of the residual plots suggested random scatter. Although Q-Q plots showed some dispersion from normality; sensitivity analyses were done by checking the outliers for errors, but no clear problems with the data were found. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 Figure A4 P Q-Q -effects model of ATM in healthy controls (above) and haemodialysis patients (below)Results of the mixed models for LTM and ATM for both healthy controls and dialysis patients.
Appendix 3
Results of the regression models for LTM and ATM for healthy controls (Tables A1 and A2) and dialysis patients (Tables A3 and A4 ).
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